Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

News Conference News EuroPCR 2025

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

May 28, 2025

TCTMD’s Top 10 Most Popular Stories for January 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2025

January 31, 2025

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

TCTMD’s Top 10 Most Popular Stories for May 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2024

May 31, 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

May 14, 2024

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

March 09, 2023

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

News Daily News

ORBITA Data Undercut the Idea PCI Does Best in Focal CAD

August 06, 2021

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

News Conference News EuroPCR 2018

ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics

Michael O'Riordan

May 31, 2018

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

News Conference News TCT 2017

FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost

November 02, 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

News Conference News TCT 2017

ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure

Michael O'Riordan

November 02, 2017

News Daily News

‘Gold Standard’ Imaging Study Undermines Venous Abnormalities Hypothesis in MS

October 11, 2013

Imaging Evaluation of CCSVI Patients

Presentation ISET 2012

Imaging Evaluation of CCSVI Patients

Presenter: Lindsay Machan

January 18, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.